软弱在心脏瘤学中的作用及其挑战
Erkihun Amsalu1, Tan Van Nguyen2,3, Harry Klimis1,4,5
1Faculty of Medicine and Health, University of Sydney Sydney, Australia.
European cardiology
|December 25, 2025
概括
虚弱显著影响癌症和心脏病的老年人. 解决心脏瘤学中的脆弱性对于更好的患者结果和个性化治疗至关重要.
科学领域:
- 心脏瘤学 - 心脏瘤学
- 老年学是指老年学的学科.
- 在瘤学瘤学.
背景情况:
- 脆弱性越来越被认为是老年人不良健康结果的预测因素.
- 在心脏瘤学中,由于癌症和心血管疾病对衰老的综合影响,脆弱性尤其重要.
- 了解脆弱性对于优化这种患者群体的患者护理至关重要.
研究的目的:
- 审查心脏瘤学中脆弱性的病理生理学.
- 讨论癌症患者的脆弱性定义和评估挑战.
- 强调需要将脆弱性纳入心血管风险评估的必要性.
主要方法:
- 这是一个复习文章.
- 关于脆弱性,心脏瘤学,心血管疾病和癌症的文献搜索.
- 综合现有的病理生理学研究,定义,评估和临床整合.
主要成果:
- 虚弱会加剧健康衰退的衰老,癌症和心血管疾病.
- 当前的脆弱性定义和评估在心脏瘤学环境中提出了挑战.
- 对于年长的癌症患者来说,将脆弱性纳入风险评估工具是必要的.
结论:
- 虚弱是心脏瘤学的关键因素,影响患者的治疗结果.
- 需要进一步的研究来阐明脆弱性和心脏毒性之间的机制.
- 为了减轻癌症患者的脆弱性相关风险的干预措施需要探索.
相关概念视频
Heart Failure I: Introduction
657
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
657
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Heart Failure II: Pathophysiology
663
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
663
Heart Failure V: Medical Management
196
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
196
Pathophysiology of Heart Failure
2.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


